|
Specially commissioned lectures by leading world experts.
The Biomedical & Life Sciences Collection
New Releases for April
|
|
|
|
This month’s release to The Biomedical & Life Sciences Collection features talks by academic and industry experts on laboratory medicine, Streptococcus pyogenes, dietary reference values, and much more.
In the Periodic Reports: Advances in Clinical Interventions and Research Platforms series, Prof. Soma Sengupta, Tufts Medical Center (USA), presents the talk ‘Leveraging healthcare data through artificial intelligence’. She provides an overview of key artificial intelligence (AI) concepts and terminology, explores the history of AI and its role in oncology, and examines its impact on clinical research, development & diagnosis. The talk also explores the applications of AI in drug discovery and development, while looking ahead to future opportunities and challenges. To ensure responsible adoption of AI, Prof. Sengupta emphasises critical considerations including data privacy, ethical use, integration into clinical workflows, and the need for regulatory compliance.
Kind regards,
The Editorial Team
|
|
|
|
|
Leveraging healthcare data through artificial intelligence
Prof. Soma Sengupta
Tufts Medical Center, USA
|
|
|
|
|
|
Dietary reference values (minerals and vitamins)
Prof. Susan Fairweather-Tait
University of East Anglia, UK
|
|
|
|
|
|
The pre-analytical phase of laboratory medicine
Prof. Giuseppe Lippi
University of Verona, Italy
|
|
|
|
|
|
Immune response to neoplasia
Dr. Yujiang Fang
Des Moines University, USA
|
|
|
|
|
|
Cooperation or competition: species interactions across environmental gradients
Dr. Alexandra Wright
University of Minnesota, USA
|
|
|
|
|
|
Use of cholera vaccine in Bangladesh: success and struggles
Dr. Firdausi Qadri
icddr,b, Bangladesh
|
|
|
|
|
|
Spinal and bulbar muscular atrophy: the great imitator
Dr. Carlo Rinaldi
University of Oxford, UK
|
|
|
|
|
|
Burkholderia cepacia
Dr. Sarah Fouch
University of Portsmouth, UK
|
|
|
|
|
|
Streptococcus pyogenes: disease and molecular pathogenesis
Prof. P. Patrick Cleary
University of Minnesota, USA
|
|
|
|
|
|
Advanced therapies in an evolving regulatory and access environment
Dr. Ana Hidalgo-Simon
Leiden University Medical Centre, The Netherlands
|
|
|
|
|
New series: Regulatory ICH Guidelines with Nonclinical Impact
|
|
|
M4 common technical dossier
Dr. Jan Willem van der Laan
Medicines Evaluation Board, The Netherlands
|
|
|
|
|
|
Nonclinical safety testing of human pharmaceuticals in relation to clinical development
Dr. Jan Willem van der Laan
Medicines Evaluation Board, The Netherlands
|
|
|
|
|
|
ICH S3A and S3B toxicokinetics and pharmacokinetics
Dr. David R. Jones
Independent Consultant PharmacoToxicologist, UK
|
|
|
|
|
New Interviews
|
|
|
Muscarinic acetylcholine receptor modulation in neurological diseases
Prof. Andrew B. Tobin
University of Glasgow, UK
|
|
|
|
|
|
Engineered yeast: a breakthrough in targeted cancer therapies
Prof. Gautam Dantas
Washington University School of Medicine, USA
|
|
|
|
|
|
De novo designed proteins: a breakthrough in snakebite treatment
Dr. Susana Vazquez Torres
University of Washington School of Medicine, USA
|
|
|
|
|
|
Rethinking the amyloid dogma in Alzheimer’s disease
Prof. George Perry
The University of Texas at San Antonio, USA
|
|
|
|
|
Featured talks from previous releases
|
|
|
|
|
|
For more specially commissioned lectures:
|
|
For assistance, contact HSTalks subscriber support:
Subscriber Support, Henry Stewart Talks Ltd
Tel: +44 (0) 20 7092 3480, Email: access@hstalks.com
Address: 40/41 Museum Street, London WC1A 1LT, United Kingdom
|
|
Follow us
|
 |
 |
|
